Surgical Innovations Group plc
(the 'Company')
Directors' Shareholdings
The Company was notified on 26 May 2016 that, on that day, Nigel Rogers and Paul Hardy, Executive Chairman and Non-Executive Director of the Company respectively, each acquired 1,140,000 ordinary shares of 1 penny each ('Shares'). The Shares were purchased at a price of 1.75 pence per Share.
Following the transaction, the beneficial holding of Nigel Rogers in the Company is 2,905,273 Shares, representing approximately 0.60% of the issued share capital of the Company.
Following the transaction, the beneficial holding of Paul Hardy in the Company (comprising the holdings of Hardy Transaction Management Limited, a company in which he has a controlling interest, and his SIPP) is 2,913,973 Shares, representing approximately 0.60% of the issued share capital of the Company.
ENDS
For further information please visitwww.sigroupplc.comor contact:
Enquiries:
For further information please contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
Melanie Ross, Group FD & Managing Director, SI Ltd | |
WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
Tim Feather/Liam Gribben | |
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Natalie Bruce | Mob: 07884 666 994 |
Surgical Innovations Group plc published this content on 27 May 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 May 2016 12:20:08 UTC.
Original documenthttp://www.sigroupplc.com/directors-shareholdings
Public permalinkhttp://www.publicnow.com/view/8E1AFE8233F7894AB2EA5A32F388AA3BF69DFD84